Chief Operating Officer, Principal Consultant, and Co-Founder at Pluristyx, Inc. - Seattle, WA, US
Pluristyx is an advanced therapy tools company helping companies and researchers solve manufacturing challenges in the field of drug development, regenerative medicine, and cell and gene therapy. Pluristyx provides seamless client support by offering CMC consulting, contract development services, cryopreservation processing, and research and clinical-grade Ready-to-Use (RTU™) and Ready-To-Differentiate® (RTD™) Pluripotent Stem Cells at a commercial scale. In doing so, Pluristyx effectively decouples the hassles of expansion and banking from differentiation and product development, allowing early-stage companies to focus precious resources on therapeutic applications rather than manufacturing hurdles, with the objective of advancing promising laboratory discoveries into patients. Pluristyx's mission is to support and accelerate the development and commercialization of revolutionary therapeutics to treat serious human diseases by providing unique products, expert consulting, and bespoke contract services. These services are customized to meet a client's unique needs, and could range from becoming embedded members of the client's own internal teams, managing activities at third-party CDMOs, or performing hands-on laboratory development and manufacturing work at Pluristyx operated facilities.